UPenn $207 Million Verdict: Chamber Urges Pennsylvania Supreme Court to Reject 'Team Liability'

The U.S. Chamber of Commerce and a coalition of business groups asked the Pennsylvania Supreme Court on October 7, 2026, to vacate the UPenn $207 million verdict, the largest medical malpractice judgment in state history, arguing that a hospital cannot be held vicariously liable when the jury never found any named physician or nurse negligent. The brief in Hagans v. Hospital of the University of Pennsylvania, No. 30 EAP 2026, frames the judgment as an unprecedented "team liability" rule, and the court's answer will set how Pennsylvania plaintiffs plead, try and draft verdict slips against hospitals for years.

The filing, reported by Law360 on October 8, is the first major amicus submission since the justices granted allocatur on July 29, 2026. It lands on top of a record already shaped by an April 2023 Philadelphia jury verdict of $182,737,791, roughly $24.9 million in delay damages added by the trial court, a unanimous Superior Court affirmance in July 2025, and repeated warnings from hospital and physician groups that the ruling will raise liability premiums statewide. What follows sets out what happened at each stage, what the Supreme Court has agreed to decide, what the Chamber argues, and what the outcome means for the personal injury bar, hospital defendants and their insurers.

What is the UPenn $207 million verdict about?

The case arises from the birth of J.H. at the Hospital of the University of Pennsylvania (HUP) in February 2018. His mother, Dajah Hagans, sued as his parent and natural guardian. The plaintiff's theory at trial was that the obstetrics team delayed a cesarean section even though the mother had a uterine infection, and that the delay, described in the Philadelphia Inquirer's coverage as about 45 minutes, caused hypoxic-ischemic encephalopathy. J.H. was left with spastic quadriplegic cerebral palsy, a seizure disorder, cortical visual impairment and profound global neurodevelopmental impairment; he cannot walk or speak and is fed through a gastrostomy tube.

HUP's defense was that the brain injury had already occurred before the mother arrived at the hospital and that the care she received met the standard of care. The jury rejected that account after a roughly three-week trial in the Philadelphia Court of Common Pleas and returned its verdict in April 2023.

The named defendants included the hospital and individual physicians and a nurse. Before trial, the parties stipulated that those providers were acting within the scope of their employment with HUP. That stipulation, and the way the verdict slip was then written around it, is the heart of the appeal now before the Supreme Court.

How did a $182.7 million verdict become a $207 million judgment?

The jury's award was $182,737,791. Reported components include about $101 million for future medical and lifetime care costs, about $1.7 million for lost future earning capacity, and about $80 million in noneconomic damages for pain and suffering. Contemporaneous reports differed on the headline number: the Inquirer read the verdict sheet as $182.7 million, plaintiff's counsel described a figure of $189.7 million, and a court spokesperson cited about $191.7 million. Law360 has used $187 million. The $182.7 million figure is the one the Superior Court and later commentary adopt.

The jump to roughly $207.6 million came from delay damages under Pennsylvania Rule of Civil Procedure 238. Rule 238 adds damages for delay in bodily injury cases at the prime rate published in the first Wall Street Journal edition of each calendar year, plus one percent, not compounded, running from one year after original process was served until the verdict. The clock stops if the defendant made a qualifying written settlement offer that the plaintiff's recovery did not exceed by more than 25 percent, or during periods of delay the plaintiff caused. Judge Gwendolyn N. Bright denied HUP's motions for judgment notwithstanding the verdict, a new trial and remittitur, added about $24.9 million in Rule 238 damages, and judgment was entered on January 19, 2024.

Stage	Date	Court	Result
Delivery and injury	February 2018	HUP, Philadelphia	J.H. born with brain injury and cerebral palsy
Jury verdict	April 2023	Philadelphia Court of Common Pleas	$182,737,791 against HUP
Post-trial ruling and judgment	January 19, 2024	Judge Gwendolyn N. Bright	Post-trial motions denied; about $24.9M delay damages; judgment about $207.6M
Superior Court affirmance	July 10, 2025	Superior Court (2025 PA Super 142)	Judgment affirmed in full
Individual providers' appeal	July 10, 2025	Superior Court (2025 PA Super 141)	Appeal quashed for lack of standing
Allocatur granted	July 29, 2026	Pennsylvania Supreme Court (No. 30 EAP 2026)	Review of vicarious liability and causation questions
Chamber coalition amicus brief	October 7, 2026	Pennsylvania Supreme Court	Urges rejection of "team liability" and vacatur
Oral argument	Not yet listed	Pennsylvania Supreme Court	Not on the September 2026 Philadelphia argument list

What did the Superior Court decide?

A three-judge Superior Court panel affirmed the judgment in a precedential opinion filed July 10, 2025. Judge McLaughlin wrote the opinion, Judge Lane joined, and Judge Stabile concurred in the result. HUP raised three main lines of attack: that the judgment had to be vacated because the jury never decided whether any individual agent was negligent, that the verdict slip improperly let the jury find liability on "increased risk of harm" alone, and that the award was excessive.

On vicarious liability, the panel held that no individual finding was required. Because the parties had stipulated to agency, because the individual providers were named on the verdict slip, and because the plaintiff proved negligence through expert testimony directed at the obstetrics team's failures, the hospital's liability rested on the conduct of its employees, which is all vicarious liability requires. The verdict slip did not list each provider separately; it asked whether HUP, acting by and through the named providers, fell below the standard of care.

On causation, the panel assumed without deciding that the trial court may have erred by putting "increased risk of harm" on the verdict slip alongside factual cause, but held that any error was harmless because the jury instructions correctly told jurors that a finding of increased risk can be a sufficient basis for finding factual cause.

On damages, the panel held that the award did not "shock the conscience," the standard Pennsylvania appellate courts apply before disturbing a jury's figure. HUP had singled out the roughly $101 million for future medical expenses and the $80 million noneconomic award.

A companion opinion issued the same day, 2025 PA Super 141, addressed a separate appeal by four individual providers, a nurse and three doctors, who argued they should have been dismissed with prejudice. The Superior Court quashed that appeal, holding that they lacked standing to challenge a judgment entered only against the hospital.

Why is the Pennsylvania Supreme Court reviewing the $207 million Penn verdict?

On July 29, 2026, the Supreme Court granted HUP's petition for allowance of appeal and docketed the case as No. 30 EAP 2026. According to the Duane Morris appellate team's summary of the grant, the court accepted two questions:

1. Vicarious liability. Whether a hospital may be held vicariously liable without an express jury finding against a specific named agent, where the providers whose conduct allegedly caused the injury were named as defendants but the verdict slip did not ask the jury to decide whether any of them was negligent.
2. Causation on the verdict slip. Whether it is reversible error to ask jurors whether negligence was a "factual cause" of harm "and/or" "increased the risk of harm," rather than requiring a factual-cause finding.

The second question resolves a direct conflict between Superior Court panels. In Lewis v. Reading Hospital, a different panel held that increased risk of harm should not be equated with factual cause and treated the "factual cause or increased risk of harm" formulation as reversible error. The Hagans panel found the same kind of formulation harmless. Both issues were preserved only because HUP objected at the charging conference to the slip's agency framing and to its pairing of factual cause with increased risk, a point appellate practitioners on both sides will note.

What is "team liability" in medical malpractice?

"Team liability" is the defense bar's label, adopted in the Chamber brief and in health-industry statements, for a judgment that holds a hospital liable for the collective performance of a care team without a jury finding that any particular team member breached the standard of care. In the critics' framing, ordinary respondeat superior requires a negligent agent first and imputes that agent's fault to the employer second; a verdict that skips the first step, they argue, converts vicarious liability into a form of direct institutional liability by another name.

Pennsylvania already recognizes direct corporate negligence claims against hospitals under Thompson v. Nason Hospital (1991), which impose duties on the institution itself (for example, to select and retain competent physicians and to oversee patient care). The Hagans plaintiff tried the case on vicarious liability, not corporate negligence, which is why the critics say the absence of an individual finding matters.

The plaintiff's answer, which the Superior Court accepted, is that nothing is skipped when the agency relationship is stipulated, the agents are named on the slip, and expert testimony identifies the negligent conduct. On that view, the jury did find negligence by HUP's employees; it simply was not asked to divide that negligence among them, and apportionment among co-employees makes no difference to a hospital that answers for all of them.

What did the U.S. Chamber argue in Hagans v. Hospital of the University of Pennsylvania?

The U.S. Chamber Litigation Center posted the coalition brief on October 7, 2026, with David R. Fine of K&L Gates as outside counsel. According to the Chamber's case summary and Law360's October 8 report, the brief argues that:

• Pennsylvania law does not recognize "team liability," and vicarious liability must rest on the negligence of a specific, identified agent.
• Because the jury made no finding against any individual employee, the judgment stretches vicarious liability into an unprecedented doctrine and should be vacated.
• The Superior Court's reasoning, if left in place, lets plaintiffs reach a hospital without proving that any one provider was negligent, which the coalition says will expand liability exposure for any enterprise that acts through teams.

The brief joins a line of institutional opposition. In July 2025, the Hospital and Healthsystem Association of Pennsylvania and other provider and business associations said the Superior Court had upheld "a $200 million vicarious liability verdict against a hospital without a jury finding that any individual provider was negligent," and warned of higher insurance premiums, facility closures and reduced access to care in underserved areas. The American Medical Association and the Pennsylvania Medical Society filed an amicus brief in the Superior Court arguing that factual cause and increased risk are not an either/or proposition and that the slip let jurors find liability on increased risk alone, which they called "contrary to Pennsylvania law."

Can a hospital be vicariously liable if no individual doctor is found negligent?

Under the Superior Court's July 2025 ruling, yes, at least where agency is stipulated, the agents are named on the verdict slip and expert testimony establishes their negligence. Whether that remains Pennsylvania law is precisely the first question the Supreme Court will decide.

There are three plausible outcomes. The court could affirm, holding that an express per-agent finding is unnecessary when agency is conceded and negligence by the team is proved. It could reverse and require a per-agent finding, which would likely mean a new trial on liability or a judgment for HUP depending on how the remedy question is framed. Or it could take a middle path, holding that a per-agent finding is generally required but that HUP's stipulation, or the way the case was tried, waived or cured the defect here. The Superior Court's quashal of the individual providers' appeal is a reminder that those providers have no judgment against them either way; the money question runs entirely to the hospital and its coverage tower.

What is the increased risk of harm standard in Pennsylvania?

Pennsylvania's increased-risk doctrine traces to Hamil v. Bashline, 481 Pa. 256 (1978), which adopted Restatement (Second) of Torts § 323 for medical malpractice. Under Hamil, once a plaintiff's expert testifies that a provider's negligent undertaking increased the risk of the harm the patient actually suffered, the case goes to the jury to decide whether that increased risk was a substantial factor in causing the harm. The plaintiff still carries the burden of proving causation by a preponderance; Hamil lowers the threshold for getting to the jury, not the burden of persuasion. Mitzelfelt v. Kamrin, 584 A.2d 888 (Pa. 1990), later reaffirmed the doctrine.

The Hagans question is narrower than whether Hamil survives. It is whether a verdict slip may present "factual cause" and "increased risk of harm" as alternative routes to liability. HUP and the physician groups say that framing lets a jury impose liability on risk alone without ever finding that the negligence caused the injury. The plaintiff's position, accepted by the Superior Court as harmless at worst, is that the jury charge tied increased risk back to factual cause, so the jury could not have found liability on risk alone.

The UPenn $207 million verdict and Pennsylvania's nuclear-verdict backdrop

The case sits in a venue that both sides of the bar watch closely. The Pennsylvania Supreme Court deleted Rule 1006(a.1), the rule that had confined medical malpractice suits to the county where the care occurred, effective January 1, 2023, after which plaintiffs could again file where a defendant regularly conducts business. The Pennsylvania Medical Society reports that Philadelphia medical malpractice filings rose to 544 in 2023, against 275 in 2022, with 41 percent of the 2023 cases arising outside the city. Hagans itself was always a Philadelphia case, because the delivery took place at HUP.

Defense firm Marshall Dennehey counts 42 nuclear verdicts in Pennsylvania between June 2021 and May 2026, 29 of them in Philadelphia, and 11 of the state's 17 medical malpractice nuclear verdicts in the city. The next-largest Philadelphia malpractice verdict after Hagans is the $108.6 million award against Jefferson Health in an Einstein birth-injury case in March 2026, which Jefferson has said it will appeal. Those figures come from defense-side and physician-group sources and support the policy argument, not the legal questions, but they explain why business groups see Hagans as a bellwether for hospital exposure across the state.

Penn's professional liability program illustrates who ultimately pays. Penn’s own finance office describes primary coverage carried through its insurance program, while the Medical Care Availability and Reduction of Error (MCARE) Fund supplies a statutory excess layer for eligible physicians. Because the judgment runs only against the hospital, how a ruling for the plaintiff would be allocated among those layers is not disclosed in the public record.

What it means for plaintiffs' firms, hospitals and insurers

For plaintiffs' medical malpractice counsel. Until the Supreme Court rules, the safer verdict slip asks the jury separately whether each named provider was negligent and whether that negligence was a factual cause of harm, with the hospital's vicarious liability flowing from any "yes." A slip built that way survives either outcome in Hagans. Counsel relying on increased risk under Hamil should consider instructing on it as a route to factual cause rather than as a freestanding alternative on the slip, which is the structure that drew the Lewis reversal.

For hospitals and health systems. The value of an agency stipulation is now contested. HUP's stipulation simplified trial but became the Superior Court's main reason for dispensing with individual findings. Defense counsel in pending cases will weigh whether to stipulate, and if so whether to condition the stipulation on per-provider questions on the slip. Hagans also shows that issues survive only if objections are made at the charging conference.

For medical professional liability insurers and the MCARE Fund. A plaintiff-side affirmance would confirm that a hospital's exposure in team-delivered care does not depend on isolating one negligent clinician, which affects reserving for obstetrics and emergency claims in Philadelphia. A reversal on the causation question would reach well beyond this case, because the "factual cause and/or increased risk" slip language is common in Pennsylvania malpractice trials.

For the broader personal injury bar and litigation funders. Business groups are explicit that their concern extends beyond hospitals to any enterprise defendant that acts through teams, including trucking, construction and product manufacturing. A broad ruling on vicarious liability without individual findings would be cited in those cases; a narrow ruling tied to HUP's stipulation would not. Funders with exposure to large Pennsylvania medical malpractice portfolios will price in the delay: Rule 238 damages stop at verdict, and post-judgment interest under 42 Pa.C.S. § 8101 governs while the appeal is pending.

When will the Pennsylvania Supreme Court decide Hagans?

No argument date has been set in the public sources reviewed. The case does not appear on the court's September 2026 Philadelphia argument list. With HUP's opening brief and supporting amicus briefs now on file, the plaintiff’s brief and any plaintiff-side amicus briefs come next, followed by argument at a later Eastern District session. Pennsylvania Supreme Court decisions in argued civil appeals typically issue months after argument, so a ruling in 2027 is the realistic expectation.

FAQ

What is the largest medical malpractice verdict in Pennsylvania?

The Hagans case against the Hospital of the University of Pennsylvania is the largest: a $182.7 million jury verdict in April 2023 that, with about $24.9 million in delay damages, became a judgment of roughly $207.6 million. It is now on appeal at the Pennsylvania Supreme Court.

Who filed the amicus brief against the UPenn $207 million verdict?

A coalition led by the U.S. Chamber of Commerce filed it on October 7, 2026, with David R. Fine of K&L Gates as outside counsel. The American Medical Association and the Pennsylvania Medical Society filed a separate amicus brief earlier in the Superior Court attacking the verdict slip's causation question.

Has the Pennsylvania Supreme Court overturned the Penn verdict?

No. The court granted review on July 29, 2026, but has not heard argument or ruled. The Superior Court's July 10, 2025 affirmance remains the controlling decision until the Supreme Court acts.

Does the Hagans appeal affect pending medical malpractice cases in Pennsylvania?

Indirectly, yes. Trial courts still apply the Superior Court's decision, but the open conflict with Lewis v. Reading Hospital and the pending review make verdict slips that combine factual cause with increased risk, or that omit per-provider findings, a known appellate risk in cases tried before the Supreme Court rules.

Were the individual doctors held liable in the Penn case?

No judgment was entered against the individual providers. The verdict ran only against HUP, and the Superior Court quashed the providers' own appeal in a companion opinion (2025 PA Super 141) because they lacked standing to challenge a judgment that did not bind them.